AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 22505744 — intervention group
Group type: EXPERIMENTAL
Intervention: Room temperature air (RA)
Number of subjects: 12
Study 20118012 — intervention group
Group type: EXPERIMENTAL
Intervention: Sevoflurane anesthesia
Number of subjects: 40
Study 20118012 — intervention group
Group type: COMPARATOR
Intervention: Propofol‐remifentanil anesthesia
Number of subjects: 40
Study 18756603 — intervention group
Group type: EXPERIMENTAL
Intervention: Compression anastomosis clip (CAC)
Number of subjects: 66
Study 18756603 — intervention group
Group type: COMPARATOR
Intervention: Stapler
Number of subjects: 66
Study 15916851 — intervention group
Group type: EXPERIMENTAL
Intervention: Platelet activation and fibrinolysis assessment in stroke patients
Number of subjects: 60
Study 15916851 — intervention group
Group type: COMPARATOR
Intervention: Matched control subjects
Number of subjects: 60
Study 12671142 — intervention group
Group type: EXPERIMENTAL
Intervention: Postal survey
Number of subjects: 450
Study 12671142 — intervention group
Group type: EXPERIMENTAL
Intervention: Fax survey
Number of subjects: 450
Study 12671142 — intervention group
Group type: EXPERIMENTAL
Intervention: E-mail survey
Number of subjects: 450
Study 12671142 — intervention group
Group type: COMPARATOR
Intervention: Mixed mode survey
Number of subjects: 450
Study 10098952 — intervention group
Group type: EXPERIMENTAL
Intervention: Transcutaneous nitroglycerine
Number of subjects: 18
Study 10098952 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 18
Study 8542163 — intervention group
Group type: EXPERIMENTAL
Intervention: Ozone exposure (250 ppb)
Number of subjects: 46
Study 8542163 — intervention group
Group type: COMPARATOR
Intervention: Filtered air (FA)
Number of subjects: 46
Study 1871492 — intervention group
Group type: EXPERIMENTAL
Intervention: Immunotherapy by oral route
Number of subjects: 0
Study 665164 — intervention group
Group type: EXPERIMENTAL
Intervention: Urea and PG F2alpha intra-amniotically
Number of subjects: 10
Study 665164 — intervention group
Group type: COMPARATOR
Intervention: PG F2alpha alone
Number of subjects: 10
Study 31227397 — intervention group
Group type: EXPERIMENTAL
Intervention: Intra-articular injection of tranexamic acid (TXA) 10 mL (100 mg/mL)
Number of subjects: 304
Study 31227397 — intervention group
Group type: EXPERIMENTAL
Intervention: Intra-articular injection of tranexamic acid (TXA)
Number of subjects: 304
Study 31227397 — intervention group
Group type: COMPARATOR
Intervention: Control group (no TXA injections)
Number of subjects: 304
Study 27881670 — intervention group
Group type: EXPERIMENTAL
Intervention: Alternate-day caloric restriction (ADCR) with 25% of total energy requirements every other day and 175% of total energy requirements every other day
Number of subjects: 20
Study 27881670 — intervention group
Group type: COMPARATOR
Intervention: Control group with three daily isoenergetic meals
Number of subjects: 20
Study 26412051 — intervention group
Group type: EXPERIMENTAL
Intervention: ASSIST-linked Brief Intervention (BI)
Number of subjects: 236
Study 26412051 — intervention group
Group type: COMPARATOR
Intervention: Simple Advice (SA)
Number of subjects: 236
Study 23624489 — intervention group
Group type: COMPARATOR
Intervention: CB1 receptor binding in SCZ patients (SCZ-T and SCZ-F)
Number of subjects: 67
Study 23624489 — intervention group
Group type: EXPERIMENTAL
Intervention: CB1 receptor binding in SCZ-F patients
Number of subjects: 67
Study 21306326 — intervention group
Group type: EXPERIMENTAL
Intervention: Intrauterine insemination (n=93, 259 cycles)
Number of subjects: 188
Study 21306326 — intervention group
Group type: COMPARATOR
Intervention: Timed intercourse with clomiphene citrate (n=95, 266 cycles)
Number of subjects: 188
Study 19801100 — intervention group
Group type: EXPERIMENTAL
Intervention: 0.2 mg/kg intraoperative dexamethasone
Number of subjects: 150
Study 19801100 — intervention group
Group type: EXPERIMENTAL
Intervention: 0.7 mg/kg intraoperative dexamethasone
Number of subjects: 150
Study 19801100 — intervention group
Group type: COMPARATOR
Intervention: Control group (no dexamethasone)
Number of subjects: 150
Study 17294139 — intervention group
Group type: EXPERIMENTAL
Intervention: Stenting with predilation
Number of subjects: 58
Study 17294139 — intervention group
Group type: COMPARATOR
Intervention: Stenting without predilation
Number of subjects: 58
Study 17294139 — intervention group
Group type: EXPERIMENTAL
Intervention: High cTFC values
Number of subjects: 58
Study 17294139 — intervention group
Group type: EXPERIMENTAL
Intervention: cTFC
Number of subjects: 58
Study 15916930 — intervention group
Group type: EXPERIMENTAL
Intervention: Variable-stiffness paediatric colonoscope
Number of subjects: 240
Study 15916930 — intervention group
Group type: COMPARATOR
Intervention: Adult colonoscope
Number of subjects: 240
Study 12837712 — intervention group
Group type: EXPERIMENTAL
Intervention: Antidepressant medication intervention (paroxetine switched to bupropion if lack of response) (n = 88)
Number of subjects: 267
Study 12837712 — intervention group
Group type: EXPERIMENTAL
Intervention: Psychotherapy intervention (8 weeks of manual-guided cognitive behavior therapy) (n = 90)
Number of subjects: 267
Study 12837712 — intervention group
Group type: COMPARATOR
Intervention: Referral to community mental health services (n = 89)
Number of subjects: 267
Study 10333940 — intervention group
Group type: EXPERIMENTAL
Intervention: Diagnosis of diabetes based on 2-h glucose load after a 75-g glucose load.
Number of subjects: 3568
Study 10333940 — intervention group
Group type: EXPERIMENTAL
Intervention: Impaired glucose tolerance assessment.
Number of subjects: 3568
Study 10333940 — intervention group
Group type: EXPERIMENTAL
Intervention: Hypertension assessment.
Number of subjects: 3568
Study 10333940 — intervention group
Group type: EXPERIMENTAL
Intervention: Smoking status assessment.
Number of subjects: 3568
Study 10333940 — intervention group
Group type: EXPERIMENTAL
Intervention: Cholesterol levels assessment in nondiabetic Singaporeans.
Number of subjects: 3568
Study 10333940 — intervention group
Group type: EXPERIMENTAL
Intervention: LDL cholesterol assessment.
Number of subjects: 3568
Study 10333940 — intervention group
Group type: EXPERIMENTAL
Intervention: HDL cholesterol assessment.
Number of subjects: 3568
Study 10333940 — intervention group
Group type: EXPERIMENTAL
Intervention: Triglyceride levels assessment.
Number of subjects: 3568
Study 7852669 — intervention group
Group type: EXPERIMENTAL
Intervention: Self-management training (7-week program)
Number of subjects: 76
Study 7852669 — intervention group
Group type: COMPARATOR
Intervention: Waiting-list control group
Number of subjects: 76
Study 2226538 — intervention group
Group type: EXPERIMENTAL
Intervention: Thrombolysis commenced later than 4-6 hours after symptom onset
Number of subjects: 386
Study 2226538 — intervention group
Group type: EXPERIMENTAL
Intervention: Thrombolysis
Number of subjects: 386
Study 2226538 — intervention group
Group type: COMPARATOR
Intervention: sigma ST increases on admission ECG
Number of subjects: 386
Study 341940 — intervention group
Group type: EXPERIMENTAL
Intervention: Mianserin hydrochloride 20 mg
Number of subjects: 9
Study 341940 — intervention group
Group type: EXPERIMENTAL
Intervention: Amitriptyline 50 mg
Number of subjects: 9
Study 341940 — intervention group
Group type: EXPERIMENTAL
Intervention: Clomipramine
Number of subjects: 9
Study 341940 — intervention group
Group type: COMPARATOR
Intervention: Mianserin 20 mg three times daily
Number of subjects: 9
Study 341940 — intervention group
Group type: COMPARATOR
Intervention: Desmethylimipramine 25 mg three times daily
Number of subjects: 9
Study 29175121 — intervention group
Group type: EXPERIMENTAL
Intervention: Elevated unmethylated insulin DNA
Number of subjects: 0
Study 29175121 — intervention group
Group type: EXPERIMENTAL
Intervention: Elevated methylated insulin DNA
Number of subjects: 0
Study 27416887 — intervention group
Group type: EXPERIMENTAL
Intervention: Fludrocortisone (50 μg oral dose)
Number of subjects: 21
Study 24368628 — intervention group
Group type: EXPERIMENTAL
Intervention: AcrySof SA60AT (Group A)
Number of subjects: 74
Study 24368628 — intervention group
Group type: COMPARATOR
Intervention: Tecnis ZCB00 (Group B)
Number of subjects: 74
Study 22867771 — intervention group
Group type: EXPERIMENTAL
Intervention: Sensor-augmented pump therapy (SAPT)
Number of subjects: 0
Study 22867771 — intervention group
Group type: COMPARATOR
Intervention: Multiple daily injections of insulin (MDI)
Number of subjects: 0
Study 22867771 — intervention group
Group type: EXPERIMENTAL
Intervention: SAPT
Number of subjects: 0
Study 22867771 — intervention group
Group type: COMPARATOR
Intervention: MDI
Number of subjects: 0
Study 20858248 — intervention group
Group type: EXPERIMENTAL
Intervention: Patient symptom assessment using EORTC QLQ-C30 version 3
Number of subjects: 1933
Study 20858248 — intervention group
Group type: COMPARATOR
Intervention: Provider symptom assessment using corresponding four-point categorical scales
Number of subjects: 1933
Study 20858248 — intervention group
Group type: EXPERIMENTAL
Intervention: Agreement assessment between patient and provider scores
Number of subjects: 1933
Study 18048858 — intervention group
Group type: EXPERIMENTAL
Intervention: Endovascular coiling
Number of subjects: 1644
Study 18048858 — intervention group
Group type: COMPARATOR
Intervention: Neurosurgical clipping
Number of subjects: 1644
Study 18048858 — intervention group
Group type: COMPARATOR
Intervention: Endovascular coiling vs Neurosurgical clipping
Number of subjects: 1644
Study 16132313 — intervention group
Group type: EXPERIMENTAL
Intervention: Propofol
Number of subjects: 60
Study 16132313 — intervention group
Group type: EXPERIMENTAL
Intervention: Propofol-ketamine
Number of subjects: 60
Study 12271805 — intervention group
Group type: EXPERIMENTAL
Intervention: Cognitive therapy for the prevention of psychosis
Number of subjects: 31
Study 12271805 — intervention group
Group type: COMPARATOR
Intervention: Non-patient controls
Number of subjects: 31
Study 10422602 — intervention group
Group type: EXPERIMENTAL
Intervention: Cognitive-behavioral therapy (CBT)
Number of subjects: 98
Study 7769060 — intervention group
Group type: EXPERIMENTAL
Intervention: Surgical ligation
Number of subjects: 95
Study 7769060 — intervention group
Group type: EXPERIMENTAL
Intervention: Radiological embolization
Number of subjects: 95
Study 7769060 — intervention group
Group type: COMPARATOR
Intervention: No treatment
Number of subjects: 95
Study 2189972 — intervention group
Group type: EXPERIMENTAL
Intervention: Composite resins
Number of subjects: 0
Study 2189972 — intervention group
Group type: COMPARATOR
Intervention: Amalgam (dispersed phase alloy)
Number of subjects: 0
Study 374444 — intervention group
Group type: EXPERIMENTAL
Intervention: Group A (ZEEP ventilation)
Number of subjects: 30
Study 374444 — intervention group
Group type: COMPARATOR
Intervention: Group B (PEEP 10 cm H2O with CPAP)
Number of subjects: 30
Study 31314108 — intervention group
Group type: EXPERIMENTAL
Intervention: darunavir/ritonavir 800/100 mg monotherapy
Number of subjects: 77
Study 28625256 — intervention group
Group type: EXPERIMENTAL
Intervention: Terlipressin (0.01-0.04 U/min)
Number of subjects: 57
Study 28625256 — intervention group
Group type: COMPARATOR
Intervention: Norepinephrine (> 1 μg/min)
Number of subjects: 57
Study 25736441 — intervention group
Group type: EXPERIMENTAL
Intervention: Dose change-based method for calculating individual patient time in therapeutic range (iTTR)
Number of subjects: 0
Study 25736441 — intervention group
Group type: COMPARATOR
Intervention: Standard Rosendaal method for calculating iTTR
Number of subjects: 0
Study 23573843 — intervention group
Group type: EXPERIMENTAL
Intervention: Jaw-thrust manoeuvre
Number of subjects: 82
Study 22010917 — intervention group
Group type: EXPERIMENTAL
Intervention: Low-poverty housing vouchers with counseling on moving
Number of subjects: 4498
Study 22010917 — intervention group
Group type: EXPERIMENTAL
Intervention: Traditional housing vouchers without counseling
Number of subjects: 4498
Study 22010917 — intervention group
Group type: COMPARATOR
Intervention: Control group (no vouchers)
Number of subjects: 4498
Study 19327603 — intervention group
Group type: EXPERIMENTAL
Intervention: Urapidil (12.5 mg, ic)
Number of subjects: 54
Study 19327603 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 54
Study 16703538 — intervention group
Group type: EXPERIMENTAL
Intervention: Zyoptix wavefront-guided PRK
Number of subjects: 56
Study 16703538 — intervention group
Group type: COMPARATOR
Intervention: Standard PRK (PlanoScan)
Number of subjects: 56
Study 14677617 — intervention group
Group type: EXPERIMENTAL
Intervention: Glass ionomer cement
Number of subjects: 27
Study 14677617 — intervention group
Group type: EXPERIMENTAL
Intervention: Polyacid-modified resin cement
Number of subjects: 27
Study 14677617 — intervention group
Group type: COMPARATOR
Intervention: Non-fluoride releasing zinc phosphate cement
Number of subjects: 27
Study 10611189 — intervention group
Group type: EXPERIMENTAL
Intervention: Melatonin 6 mg orally every day at 1700 h for 1 month
Number of subjects: 6
Study 10611189 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 6
Study 10611189 — intervention group
Group type: EXPERIMENTAL
Intervention: Melatonin 6 mg
Number of subjects: 6
Study 10611189 — intervention group
Group type: COMPARATOR
Intervention: Baseline
Number of subjects: 6
Study 9189814 — intervention group
Group type: EXPERIMENTAL
Intervention: Elastase (10800 EL. U. P.O. per day) with an antiplatelet drug
Number of subjects: 104
Study 9189814 — intervention group
Group type: COMPARATOR
Intervention: Control group (only antiplatelet drug)
Number of subjects: 104
Study 9189814 — intervention group
Group type: EXPERIMENTAL
Intervention: Elastase (10800 EL. U. P.O. per day) with an antiplatelet drug (when autogenous saphenous veins were used)
Number of subjects: 104
Study 9189814 — intervention group
Group type: COMPARATOR
Intervention: Control group (only antiplatelet drug, when autogenous saphenous veins were used)
Number of subjects: 104
Study 1487662 — intervention group
Group type: EXPERIMENTAL
Intervention: Calcium sodium alginate fibre (Kaltostat)
Number of subjects: 40
Study 1487662 — intervention group
Group type: COMPARATOR
Intervention: Petrolatum gauze impregnated with bismuth tribromophenate (Xeroform)
Number of subjects: 40
Study 3887547 — intervention group
Group type: EXPERIMENTAL
Intervention: Ranitidine (150 mg twice daily)
Number of subjects: 119
Study 3887547 — intervention group
Group type: COMPARATOR
Intervention: Antacid (Novaluzid; 10 ml seven times daily, with a neutralizing capacity of 600 mmol H+)
Number of subjects: 119
Study 3887547 — intervention group
Group type: EXPERIMENTAL
Intervention: Whole groups (combined results)
Number of subjects: 119
Study 31421138 — intervention group
Group type: EXPERIMENTAL
Intervention: Real-time continuous glucose monitoring (RT-CGM)
Number of subjects: 20
Study 31421138 — intervention group
Group type: COMPARATOR
Intervention: Blinded continuous glucose monitoring (Blinded-CGM)
Number of subjects: 20
Study 29651052 — intervention group
Group type: EXPERIMENTAL
Intervention: Continuous subcutaneous insulin infusion (CSII) therapy
Number of subjects: 102
Study 29651052 — intervention group
Group type: COMPARATOR
Intervention: Insulin glargine based multiple injections (MDI) therapy
Number of subjects: 102
Study 26089214 — intervention group
Group type: EXPERIMENTAL
Intervention: Aspheric toric intraocular lens (IOL) implantation
Number of subjects: 60
Study 26089214 — intervention group
Group type: COMPARATOR
Intervention: Limbal relaxing incisions (LRI)
Number of subjects: 60
Study 25172269 — intervention group
Group type: EXPERIMENTAL
Intervention: Restrictive baseline symptom severity thresholds
Number of subjects: 0
Study 22732135 — intervention group
Group type: EXPERIMENTAL
Intervention: Self-monitoring of mood, stress, and daily activities for 2 to 4 weeks.
Number of subjects: 114
Study 22732135 — intervention group
Group type: COMPARATOR
Intervention: Attention comparison group (only daily activities monitored) for 2 to 4 weeks.
Number of subjects: 114
Study 20032123 — intervention group
Group type: COMPARATOR
Intervention: Concomitant chemoradiotherapy (CT/RT) alone (arm A: two cycles of cisplatin 20 mg/m(2), days 1-4, plus 5‐fluorouracil 800 mg/m(2)/day 96 h continuous infusion during weeks 1 and 6 of radiotherapy)
Number of subjects: 101
Study 20032123 — intervention group
Group type: EXPERIMENTAL
Intervention: Induction docetaxel, cisplatin and 5‐fluorouracil (TPF) followed by concomitant chemoradiotherapy (arm B: three cycles of TPF: docetaxel 75 mg/m(2) and cisplatin 80 mg/m(2), day 1, and 5‐fluorouracil 800 mg/m(2)/day 96 h continuous infusion, every 3 weeks)
Number of subjects: 101
Study 18614721 — intervention group
Group type: COMPARATOR
Intervention: Exercise
Number of subjects: 15
Study 18614721 — intervention group
Group type: COMPARATOR
Intervention: Niacin
Number of subjects: 15
Study 18614721 — intervention group
Group type: COMPARATOR
Intervention: Niacin + Exercise
Number of subjects: 15
Study 18614721 — intervention group
Group type: COMPARATOR
Intervention: Control (high-fat meal only)
Number of subjects: 15
Study 15824925 — intervention group
Group type: EXPERIMENTAL
Intervention: Revascularisation
Number of subjects: 384
Study 15824925 — intervention group
Group type: COMPARATOR
Intervention: No revascularisation (Control)
Number of subjects: 384
Study 12456227 — intervention group
Group type: EXPERIMENTAL
Intervention: BMI of 30 or greater
Number of subjects: 21414
Study 12456227 — intervention group
Group type: EXPERIMENTAL
Intervention: Each unit increase of BMI
Number of subjects: 21414
Study 12456227 — intervention group
Group type: EXPERIMENTAL
Intervention: Adjustment for hypertension, diabetes mellitus, and hypercholesterolemia
Number of subjects: 21414
Study 10834024 — intervention group
Group type: EXPERIMENTAL
Intervention: Calcium and vitamins (30,000 IU vitamin A, 1 g vitamin C, 70 mg vitamin E, 2 g calcium)
Number of subjects: 90
Study 10834024 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 90
Study 10834024 — intervention group
Group type: EXPERIMENTAL
Intervention: Calcium and vitamins (after 6 months discontinuation)
Number of subjects: 90
Study 10834024 — intervention group
Group type: COMPARATOR
Intervention: Placebo (after 6 months discontinuation)
Number of subjects: 90
Study 8861437 — intervention group
Group type: EXPERIMENTAL
Intervention: Gelseal Vascutek graft immersed for 15 min in a solution containing 1 mg/ml rifampicin (group A)
Number of subjects: 600
Study 8861437 — intervention group
Group type: COMPARATOR
Intervention: Untreated Gelseal Vascutek graft (group B)
Number of subjects: 600
Study 1403864 — intervention group
Group type: EXPERIMENTAL
Intervention: Fluid wax
Number of subjects: 30
Study 1403864 — intervention group
Group type: COMPARATOR
Intervention: Light-body polysulfide rubber
Number of subjects: 30
Study 6147067 — intervention group
Group type: COMPARATOR
Intervention: Basal therapy (B) with monthly appointments
Number of subjects: 23
Study 6147067 — intervention group
Group type: EXPERIMENTAL
Intervention: Therapist-directed prolonged exposure in vivo (PE)
Number of subjects: 23
Study 6147067 — intervention group
Group type: EXPERIMENTAL
Intervention: Relaxation therapy (R)
Number of subjects: 23
Study 30601319 — intervention group
Group type: EXPERIMENTAL
Intervention: ACEIs-combined (n = 369)
Number of subjects: 470
Study 27486681 — intervention group
Group type: EXPERIMENTAL
Intervention: Tübingen exercise therapy approach (THüKo)
Number of subjects: 210
Study 27486681 — intervention group
Group type: COMPARATOR
Intervention: Placebo ultrasound
Number of subjects: 210
Study 27486681 — intervention group
Group type: COMPARATOR
Intervention: Control group (no treatment)
Number of subjects: 210
Study 25290345 — intervention group
Group type: EXPERIMENTAL
Intervention: Autonomy (free timing of break)
Number of subjects: 60
Study 25290345 — intervention group
Group type: COMPARATOR
Intervention: Standard conditions (fixed timing of break)
Number of subjects: 60
Study 25290345 — intervention group
Group type: EXPERIMENTAL
Intervention: Increased autonomy
Number of subjects: 60
Study 23379535 — intervention group
Group type: EXPERIMENTAL
Intervention: HEIA intervention
Number of subjects: 700
Study 21958650 — intervention group
Group type: EXPERIMENTAL
Intervention: Delayed reaction time task mimicking encoding, rehearsal, and recall stages of VSTM
Number of subjects: 0
Study 18840133 — intervention group
Group type: EXPERIMENTAL
Intervention: Immunohistochemical analysis using Ber‐EP4 antibody
Number of subjects: 20
Study 18840133 — intervention group
Group type: EXPERIMENTAL
Intervention: Immunohistochemical analysis using AE1/AE3 antibody
Number of subjects: 20
Study 18840133 — intervention group
Group type: EXPERIMENTAL
Intervention: Immunohistochemical analysis using CAM 5.2 antibody
Number of subjects: 20
Study 18840133 — intervention group
Group type: EXPERIMENTAL
Intervention: Presence of nodal micrometastases
Number of subjects: 20
Study 16504324 — intervention group
Group type: EXPERIMENTAL
Intervention: L. plantarum MF1298
Number of subjects: 17
Study 16504324 — intervention group
Group type: EXPERIMENTAL
Intervention: L. pentosus DC13
Number of subjects: 17
Study 16504324 — intervention group
Group type: EXPERIMENTAL
Intervention: L. plantarum MF1298 (as sausage)
Number of subjects: 17
Study 16504324 — intervention group
Group type: EXPERIMENTAL
Intervention: L. pentosus DC13 (as sausage)
Number of subjects: 17
Study 12771612 — intervention group
Group type: EXPERIMENTAL
Intervention: Helium/oxygen mixture
Number of subjects: 13
Study 12771612 — intervention group
Group type: COMPARATOR
Intervention: Air/oxygen mixture
Number of subjects: 13
Study 11062570 — intervention group
Group type: EXPERIMENTAL
Intervention: Topical lignocaine‐prilocaine anaesthetic cream
Number of subjects: 19
Study 11062570 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 19
Study 9258888 — intervention group
Group type: EXPERIMENTAL
Intervention: 15 ml/kg of lactated ringer intravenously as prehydration
Number of subjects: 44
Study 9258888 — intervention group
Group type: COMPARATOR
Intervention: Trendelenbourg position to 30 degrees for 2 minutes and legs wrapped with elastic Esmarch bandage
Number of subjects: 44
Study 8488820 — intervention group
Group type: EXPERIMENTAL
Intervention: Cuprophan membrane (CU)
Number of subjects: 20
Study 8488820 — intervention group
Group type: EXPERIMENTAL
Intervention: Hemophan membrane (HE)
Number of subjects: 20
Study 8488820 — intervention group
Group type: EXPERIMENTAL
Intervention: Polyamide membrane (PA)
Number of subjects: 20
Study 8488820 — intervention group
Group type: EXPERIMENTAL
Intervention: Polyamide membrane, large dialyzer area, low Qb for 4 hours
Number of subjects: 20
Study 8488820 — intervention group
Group type: EXPERIMENTAL
Intervention: Polyamide dialysis at low Qb for 4 hours
Number of subjects: 20
Study 8488820 — intervention group
Group type: EXPERIMENTAL
Intervention: Polyamide dialysis at high Qb for 2 hours
Number of subjects: 20
Study 3032640 — intervention group
Group type: EXPERIMENTAL
Intervention: Gaviscon
Number of subjects: 20
Study 3032640 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 20
Study 2685045 — intervention group
Group type: EXPERIMENTAL
Intervention: Tailored psychological treatment of insomnia
Number of subjects: 0